Introduction {#Sec1}
============

Necrosis results from several types of insults and presents with morphologically distinct patterns. In the anterior pituitary, necrosis is usually of vascular origin and more often associated with pituitary adenomas (Table [1](#Tab1){ref-type="table"}). It is found at surgery or during pathological examination of the resected sellar mass \[[@CR3]\], often accompanied by hemorrhages (hemorrhagic necrosis). In a minority of cases, it develops so rapidly and extensively that it causes a sudden increase in the size of the pituitary gland accompanied by symptoms such as headache, visual disturbances, ophthalmoplegia, nausea, vomiting, and altered mental status, an emergency condition known as pituitary apoplexy. Pituitary necrosis is also typical of Sheehan syndrome. It is an ischemic necrosis resulting from the hypotension that ensues after severe uterine bleeding at the time of delivery \[[@CR4]\]. It typically results in gradual hypopituitarism that may remain unrecognized for years; however, a few patients may develop acute pituitary apoplexy.Table 1Etiology of pituitary necrosisTumorousPituitary adenomaPituitary metastasesIschemicSheehan syndromeThrombotic/HypercoagulativeAntepartum necrosis of gestational diabetesSeptic shockAutoimmuneHypophysitisMechanicalElevated intracranial pressure (secondary to subarachnoidal hemorrhage, basilar artery thrombosis)MiscellaneousPituitary stimulation testSpinal anesthesiaSnake venom poisoning

In very rare cases, necrosis is observed in hypophysitis, a chronic inflammation of the pituitary gland that comprises two more common forms, lymphocytic and granulomatous, and two rarer forms, xanthomatous and IgG4 plasmacytic \[[@CR1], [@CR2]\]. In these forms, necrosis is typically limited to small areas and does not dominate the histopathological picture \[[@CR2]\]. In 1993, however, Ahmed and colleagues described 2 patients with a fifth pathological variant they called necrotizing infundibulo-hypophysitis \[[@CR3]\]. They reported two young men with central diabetes insipidus, partial hypopituitarism, and MRI features suggestive of hypophysitis (enlarged anterior pituitary and thickened stalk) who underwent pituitary surgery. Analysis of the resected tissue showed extensive necrosis surrounded by a lympho-plasmacytic infiltration and fibrosis, with only scattered areas of glandular tissue remaining. A third case was reported in the Japanese literature in a 14 year-old boy with a prolonged history of diabetes insipidus, but the diagnosis of necrotizing infundibulo-neurohypophysitis was established without pituitary biopsy, so its classification remains uncertain \[[@CR4]\].

We report here the third case of biopsy-proven necrotizing infundibulo-hypophysitis in a young woman who presented with severe headache and secondary amenorrhea and was carefully followed up for 1 year after pituitary surgery.

Case report {#Sec2}
===========

A 20 year-old woman with a three-year history of migraine and secondary amenorrhea suddenly developed severe retroorbital headache and neck pain. Physical examination and visual acuity were normal. Visual fields could not be assessed because headache rendered the ophthalmic perimetry intolerable, despite sufficient analgesic coverage.

Magnetic resonance imaging (MRI) revealed a 22 × 20 × 16 mm pituitary mass with slight suprasellar extension (Fig. [1](#Fig1){ref-type="fig"}). The pituitary mass was iso- to hyperintense on T2- (Fig. [1](#Fig1){ref-type="fig"}a) and hyperintense on T1-weighted images (Fig. [1](#Fig1){ref-type="fig"}b). The typical posterior pituitary bright spot was absent (Fig. [1](#Fig1){ref-type="fig"}d). After i.v. contrast (gadolinium), only slight to moderate and inhomogeneous enhancement occurred, most pronounced in the periphery of the mass (Fig. [1](#Fig1){ref-type="fig"}c). The pituitary stalk and infundibulum were slightly thickened and showed avid enhancement (Fig. [1](#Fig1){ref-type="fig"}e).Fig. 1Magnetic resonance imaging before surgery. The 22 × 20 × 16 mm pituitary mass is iso- to hyperintense on T2 with suprasellar extension (**a**) and hyperintense in T1-weighted, non-enhanced images. The typical posterior pituitary bright spot is absent (**d**). After i.v. contrast (**c**), only slight to moderate and inhomogeneous enhancement occurs, most pronounced at the periphery of the mass. The pituitary stalk and infundibulum are slightly *thickened* showing avid enhancement (**d**)Fig. 2Magnetic resonance imaging at 6 and 9 months after surgery. Six months after surgery, MRI revealed a left intrasellar cyst of 4 × 7 × 6 mm (**a**) with normal-appearing anterior pituitary and pituitary stalk, not enhancing after gadolinium (**b**). There is still no normal T1 hyperintense signal of the posterior pituitary (**c**). Nine months after surgery MRI demonstrates a normal anterior pituitary and pituitary stalk with normal enhancement (**d**--**f**), but the normal posterior pituitary bright spot in non-enhanced T1 images is still lacking (*not shown*)

Assessment of pituitary function revealed increased prolactin and secondary hypogonadism (Table [2](#Tab2){ref-type="table"}). Thyroid, adrenal, and growth hormone axes were normal. A diagnosis of non-secreting macroadenoma with pituitary apoplexy was established based on clinical findings and imaging. The patient was started on hydrocortisone (40 mg/day) and prepared for surgery. A transseptal transsphenoidal surgical approach to the pituitary was performed 2 days after the onset of headaches.Table 2Endocrinological characteristics before and after pituitary surgeryHormoneReference valueMethod2 days before surgery3 months after surgery6 months after surgeryProlactin91--552 mU/lECLIA*6281,955*108LH0.8--8.3 mU/mlECLIA*0.70.60.6*^a^FSH1.2--10.1 mU/mlECLIA*0.520.81.0*^a^Estradiol30--330 pg/mlECLIA\<*7.0*\<*7.0*116.8^a^TSH0.45--3.20 mU/lECLIA0.873.810.50fT32.4--4.4 ng/lECLIA2.92.92.5fT48.9--17.0 ng/lECLIA12.79.5*7.4*ACTH7.2--63.3 μg/lECLIA10.3*6.9*\<*1.0*^b^Cortisol (baseline)5--25 μg/dlECLIA7284^c^415^b^Cortisol (30 min after 250 μg ACTH)\>30 μg/dlECLIAnm*112*nmCortisol (60 min after 250 μg ACTH)\>70 μg/dlECLIAnm*137*nmGH\<6.88 μg/lCLA1.1nmnmIGF-1108--247 μg/lCLAnm156*98*nm: not measuredECLIA: electrochemiluminescencs assay (Roche Diagnostics, Mannheim, Germany)CLIA: chemiluminescens immuno assay (DiaSorin, Dietzenbach, Germany)Italics within this table are used for pathological values^a^Under estradiol substitution^a,b^Under hydrocortisone substitution^c^Two days after discontinuing hydrocortisone

Opening of the sella revealed no hemorrhage but rather a fleshy, gum-like mass intimately connected with a rubbery pituitary. The components of the gland that appeared pathological were completely removed. The remaining gland was inspected extensively and showed no other areas suggestive of tumor or hemorrhage.

Pathological evaluation of the excised tissue revealed no adenoma. The key feature was instead an abundance of necrotic tissue with only small areas of anterior and posterior pituitary remaining. These areas were heavily infiltrated by mononuclear cells (Fig. [3](#Fig3){ref-type="fig"}a, b), with abundant CD8-positive cytotoxic T cells in both anterior (Fig. [3](#Fig3){ref-type="fig"}c, d) and posterior pituitary (Fig. [3](#Fig3){ref-type="fig"}e, f). The remaining anterior pituitary showed acini of secretory cells surrounded by a reticulin-rich network. Single cells were positive when stained for the different hormones (ACTH, GH, TSH, FSH, LH, PRL). Small areas of the posterior pituitary showed regular pituicytes with partial expression of glial fibrillary acidic protein (GFAP).Fig. 3Necrosis and T cell inflammation of pituitary. Anterior pituitary shows partial necrosis (**a**, HE ×40) with infiltration by numerous macrophages (**b**, KiM1P ×40). Necrotic areas in the upper part are marked by *arrows*. T cell infiltrates with high numbers of cytotoxic T cells are found in the anterior pituitary (**c**, CD3 ×40, and **d**, CD8 ×40) as well as posterior pituitary (**e**, CD3 ×40 and **f**, CD8 ×40). Original magnification: **a**, **b** ×10, **c**--**f** ×20. *Scale bar* 100 μm

After surgery the patient developed diabetes insipidus, which was treated with desmopressin replacement, as well as adynamia despite hydrocortisone therapy. At the 3 month follow-up, the headaches had ceased, the initial hormonal defects (hyperprolactinemia and secondary hypogonadism) persisted (Table [2](#Tab2){ref-type="table"}), the diabetes insipidus was controlled by desmopressin (spray every 16 h), and a secondary adrenal insufficiency was detected by an ACTH stimulation test (serum cortisol measured after intravenous 250 μg of ACTH) (Table [2](#Tab2){ref-type="table"}). Six months after surgery, normoprolactinemia was seen under estradiol substitution, but decreased free thyroxine (7.4 ng/l) and inappropriately normal TSH values (0.5 mU/l) indicated the appearance of secondary hypothyroidism, and decreased IGF-1 levels (98 μg/l) a concomitant growth hormone deficiency. Adynamia improved after initiation of thyroxine replacement (50 μg/day) and continuation of hydrocortisone (then 20 mg/day). Overall this progression to panhypopituitarism suggested that, despite surgical removal of the inflamed and necrotic pituitary mass, the remaining pituitary parenchyma was still targeted by the autoimmune attack. Up to the present, the patient has not been affected by other autoimmune diseases.

Control cranial MRI were performed 6 and 9 months after surgery. At 6 months, the anterior pituitary and the stalk appeared normal in size (Fig. [2](#Fig2){ref-type="fig"}a), but there was still no normal T1 hyperintense signal in the posterior pituitary (Fig. [2](#Fig2){ref-type="fig"}c). A 4 × 7 × 6 mm sized cyst was also found in the left sellar region. After administration of gadolinium (Fig. [2](#Fig2){ref-type="fig"}b), the remaining anterior pituitary and stalk were physiologically enhanced but no enhancement of the intrasellar cyst was observed. At 9 months, the anterior pituitary and stalk maintained their normal size and enhanced normally (Fig. [2](#Fig2){ref-type="fig"}d--f). The physiologic posterior pituitary bright spot in non-enhanced T1 images was still lacking (data not shown), and the left intrasellar cyst had disappeared.

Discussion {#Sec3}
==========

We describe a case of hypophysitis with inflammatory infiltration of the anterior and posterior pituitary and partial necrosis of the anterior pituitary, consistent with the diagnosis of necrotizing infundibulo-hypophysitis. This condition is extremely rare; only 3 cases have been previously reported, diagnosed in two patients \[[@CR3]\], and suspected in a third \[[@CR4]\]. The diagnosis of necrotizing infundibulo-hypophysitis is based solely on pathological examination of the resected pituitary since the clinical presentation and the MRI appearance do not differ from other more common forms of hypophysitis. The more common forms of hypophysitis are lymphocytic, granulomatous and xanthomatous \[[@CR1]\]. Patients with necrotizing infundibulo-hypophysitis present acutely with sudden and severe headache and develop a complete and long-lasting hypopituitarism, features that can, however, be seen in other non-secreting pituitary masses \[[@CR5]\]. MRI reveals symmetrical enlargement of the pituitary gland without signs of hemorrhage, as well as a thickened, pathologically enhancing stalk, features that again are not specific enough to establish a diagnosis before pituitary surgery. Confirmation of the diagnosis of necrotizing infundibulo-hypophysitis, as in other forms of hypophysitis, requires the pathological examination of the surgically removed pituitary specimen.

The key diagnostic feature of necrotizing infundibulo-hypophysitis is a marked mononuclear infiltrate within pituitary tissue showing significant necrosis. Pituitary necrosis can be found in various conditions (Table [1](#Tab1){ref-type="table"}), most commonly in adenomas with apoplexy \[[@CR6], [@CR7]\] and Sheehan syndrome \[[@CR8], [@CR9]\]. Pituitary necrosis is also seen in gestational diabetes mellitus \[[@CR10]\], hypophysitis, and sporadically after pituitary stimulation tests \[[@CR11]\], spinal anesthesia \[[@CR12]\], or snake poisoning \[[@CR13]\]. In routine autopsy series, pituitary necrosis is found in about 10% of cases without neoplasms \[[@CR14]\]. In the majority of published series on pituitary apoplexy, no differentiation is made between pure infarction or infarction with hemorrhage, and very few cases of pituitary apoplexy due to pure infarction have therefore been described \[[@CR7], [@CR15]--[@CR18]\]. In cases with pituitary adenoma apoplexy, a peripheral rim enhancement is seen in those cases in which the interval between symptom onset and surgery constituted several weeks to months \[[@CR18]\]. Pathologically, the enhancing rim corresponds to proliferating connective tissue, mononuclear cell infiltration, and atrophic endocrine cells at the edge of the infarction or hemorrhage. In general, however, pituitary necrosis is not accompanied by the marked lymphocytic infiltration seen in patients with infundibulo-neurohypophysitis, suggesting an autoimmune pathogenesis for this form.

Necrosis and apoptosis are tightly linked with autoimmunity. Apoptosis is a form of programmed cell death during which the cell order is dismantled, usually with fragmentation and release of apoptotic bodies. During this process the cytoplasmic membrane rearranges but remains intact so that no inflammatory reaction is elicited. The rearranged cell surface allows the binding of numerous factors such as the complement factor C1q \[[@CR19]\] and the milk factor globule epidermal growth factor 8 \[[@CR20]\] that suppress inflammation and promote the engulfment by macrophages and dendritic cells \[[@CR21]\]. However, if the apoptotic cell is not removed promptly and efficiently, it progresses to a state of secondary necrosis in which the cytoplasmic membrane is eventually disrupted. The cell then becomes pro-inflammatory rather than immunosuppressive, capable of activating dendritic cells and lymphocytes \[[@CR22]\]. In fact, failed removal of apoptotic cells is known to be associated with autoimmunity in both mice and humans \[[@CR23]\]. The mechanisms through which an incompletely removed apoptotic cell favors initiation and propagation of an autoimmune response remain to be elucidated. Autoantigens may reach unusually high concentrations in apoptotic bodies or undergo post-translational modifications that make them better recognizable by the immune system. The pro-inflammatory environment can also lead to expression of class II MHC molecules on cells. In fact, pituitary cells are able to synthetize MHC class II molecules in experimental settings \[[@CR24]\] as well as in patients with lymphocytic hypophysitis \[[@CR1]\], which makes these cells ideally capable of interacting with activated immunocompetent cells. Moreover, experimental evidence suggests that not only neoplastic but also normal pituitary can support an inflammatory reaction via expression of multiple cytokines, including IL-1, IL-1 receptor agonist, IL-2, and IL-6 \[[@CR25]\]. In pituitary necrosis, these cytokines may serve as an abnormal stimulant that elicits systemic or local inflammation, which can induce hypophysitis in the neighboring, residual normal gland. The small number of reported patients with necrotizing hypophysitis and the absence of an animal model specific for this pathological variant make it difficult to draw any conclusions.

Another possible scenario is the spontaneous development of pituitary necrosis that is without recognizable precipitating events as previously described \[[@CR26]\]. Such a scenario seems unlikely in our young patient particularly since the necrosis was associated with lymphocytic infiltration of the remaining anterior and even posterior pituitary. We therefore think that the necrosis was secondary to the inflamed and enlarged pituitary gland, which is in keeping with the observation that the patient suffered from secondary hypogonadism for 3 years. After the gonadotropin insufficiency, our patient developed corticotropin, thyrotropin and growth hormone deficiency as well as diabetes insipidus. However, a spontaneous reduction in the size of her pituitary gland after surgical biopsy, along with a normal-appearing anterior pituitary and infundibulum, was demonstrated in consecutive MR control images. The posterior pituitary bright spot still did not reappear. Deficiency of the anterior and posterior pituitary function in our patient might be explained by ongoing autoimmune destruction of the gland. This autoimmune reaction is either primary, as would be the case in autoimmune hypophysitis preceding pituitary apoplexy, or secondary, as necrosis of the pituitary is known to initiate the liberation of autoantigens from the damaged cells, triggering secondary autoimmune process through pituitary autoantibodies \[[@CR27]\]. The latter can not be proven in our case, as no pituitary antibodies were measured in our patient.

In conclusion, we report a young woman with diabetes insipidus and hypopituitarism, demonstrating a characteristic MRI appearance with symmetrical gland enlargement, loss of posterior pituitary bright spot, thickening and pathological enhancement of the pituitary stalk and infundibulum, as is usually seen in autoimmune hypophysitis \[[@CR28]\]. Histopathology showed massive pituitary, non-hemorrhagic necrosis and lymphocytic infiltration of the normal-appearing anterior and posterior pituitary, as reported in two previously published cases of necrotizing infundibulo-hypophysitis \[[@CR3]\]. The pathogenesis of this rare hypophysitis variant remains unknown.
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